"Getting addiction off the streets and alleyways – and one step closer to treatment – is a win for all of society." ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
A new study out of Canada identified 12 modifiable risk factors for dementia in people aged 45 and older. The researchers say ...